EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Fabrication of Polypill Pharmaceutical Dosage Forms Using Fused Deposition Modeling 3D Printing: A Systematic Review

Haya Yasin iD, Moawia M A Al-Tabakha iD, Siok Yee Chan iD

Pharmaceutics · 30.09.2024 · 16 (10) · 1285

DOI: 10.3390/pharmaceutics16101285 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 30.09.2024. Verfasst von Haya Yasin und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Pulau Pinang, Malaysia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The pharmacy profession has undergone significant changes driven by advancements in patient care and healthcare systems. The FDA approval of Spritam® (levetiracetam), the first 3D-printed drug, has sparked increased interest in the use of Fused Deposition Modeling (FDM) 3D printing for pharmaceutical applications, particularly in the production of polypills.

Methods

This review provides an overview of FDM 3D printing in the development of pharmaceutical dosage forms, focusing on its operation, printing parameters, materials, additives, advantages, and limitations. Key aspects, such as the ability to personalize medication and the challenges associated with the technique, including drug stability at high temperatures, are discussed.

Results

Fourteen studies relevant to FDM 3D-printed polypills were analyzed from an initial pool of 60. The increasing number of publications highlights the growing global interest in this technology, with the UK contributing the highest number of studies.

Conclusions

FDM 3D printing offers significant potential for personalized medicine by enabling precise control over dosage forms and tailoring treatments to individual patient needs. However, limitations such as high printing temperatures and the lack of standardized GMP guidelines for large-scale production must be addressed to fully realize its potential in pharmaceutical manufacturing.

Schlagwörter

Stichwörter der Autor:innen

3D drug printingdosage formdrug deliverydrug manufacturingfused deposition modelingpersonalized medicine

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Pulau Pinang, Malaysia.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman P.O. Box 346, United Arab Emirates.

ORCID-Profile: Haya Yasin, Moawia M A Al-Tabakha, Siok Yee Chan

Zitieren

APA

Yasin, H., Al-Tabakha, M. M. A., & Chan, S. Y. (2024). Fabrication of Polypill Pharmaceutical Dosage Forms Using Fused Deposition Modeling 3D Printing: A Systematic Review. Pharmaceutics, 16(10), 1285. https://doi.org/10.3390/pharmaceutics16101285

Vancouver

Yasin H, Al-Tabakha MMA, Chan SY. Fabrication of Polypill Pharmaceutical Dosage Forms Using Fused Deposition Modeling 3D Printing: A Systematic Review. Pharmaceutics. 2024;16(10):1285. doi:10.3390/pharmaceutics16101285

BibTeX
@article{Yasin2024,
  author = {Yasin, Haya and Al-Tabakha, Moawia M A and Chan, Siok Yee},
  title = {Fabrication of Polypill Pharmaceutical Dosage Forms Using Fused Deposition Modeling 3D Printing: A Systematic Review},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1285},
  doi = {10.3390/pharmaceutics16101285}
}
Kostenlos starten →